Hung MH - Search Results

1

SHP-1 is a target of regorafenib in colorectal cancer.

Fan LC, Teng HW, Shiau CW, Lin H, Hung MH, Chen YL, Huang JW, Tai WT, Yu HC, Chen KF. Fan LC, et al. Among authors: hung mh. Oncotarget. 2014 Aug 15;5(15):6243-51. doi: 10.18632/oncotarget.2191. Oncotarget. 2014. PMID: 25071018 Free PMC article.

2

Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.

Liu CY, Su JC, Ni MH, Tseng LM, Chu PY, Wang DS, Tai WT, Kao YP, Hung MH, Shiau CW, Chen KF. Liu CY, et al. Among authors: hung mh. Breast Cancer Res Treat. 2014 Jul;146(1):71-84. doi: 10.1007/s10549-014-3000-0. Epub 2014 Jun 6. Breast Cancer Res Treat. 2014. PMID: 24903225

3

STAT3 mediates regorafenib-induced apoptosis in hepatocellular carcinoma.

Tai WT, Chu PY, Shiau CW, Chen YL, Li YS, Hung MH, Chen LJ, Chen PL, Su JC, Lin PY, Yu HC, Chen KF. Tai WT, et al. Among authors: hung mh. Clin Cancer Res. 2014 Nov 15;20(22):5768-76. doi: 10.1158/1078-0432.CCR-14-0725. Epub 2014 Sep 23. Clin Cancer Res. 2014. PMID: 25248379

4

Downregulation of signal transducer and activator of transcription 3 by sorafenib: a novel mechanism for hepatocellular carcinoma therapy.

Hung MH, Tai WT, Shiau CW, Chen KF. Hung MH, et al. World J Gastroenterol. 2014 Nov 7;20(41):15269-74. doi: 10.3748/wjg.v20.i41.15269. World J Gastroenterol. 2014. PMID: 25386075 Free PMC article. Review.

5

Pharmacological Targeting SHP-1-STAT3 Signaling Is a Promising Therapeutic Approach for the Treatment of Colorectal Cancer.

Fan LC, Teng HW, Shiau CW, Tai WT, Hung MH, Yang SH, Jiang JK, Chen KF. Fan LC, et al. Among authors: hung mh. Neoplasia. 2015 Sep;17(9):687-696. doi: 10.1016/j.neo.2015.08.007. Neoplasia. 2015. PMID: 26476076 Free PMC article.

6

SET antagonist enhances the chemosensitivity of non-small cell lung cancer cells by reactivating protein phosphatase 2A.

Hung MH, Wang CY, Chen YL, Chu PY, Hsiao YJ, Tai WT, Chao TT, Yu HC, Shiau CW, Chen KF. Hung MH, et al. Oncotarget. 2016 Jan 5;7(1):638-55. doi: 10.18632/oncotarget.6313. Oncotarget. 2016. PMID: 26575017 Free PMC article.

7

A combination of sorafenib and SC-43 is a synergistic SHP-1 agonist duo to advance hepatocellular carcinoma therapy.

Chao TI, Tai WT, Hung MH, Tsai MH, Chen MH, Chang MJ, Shiau CW, Chen KF. Chao TI, et al. Among authors: hung mh. Cancer Lett. 2016 Feb 28;371(2):205-13. doi: 10.1016/j.canlet.2015.11.039. Epub 2015 Dec 8. Cancer Lett. 2016. PMID: 26679051

8

Protein tyrosine phosphatase 1B dephosphorylates PITX1 and regulates p120RasGAP in hepatocellular carcinoma.

Tai WT, Chen YL, Chu PY, Chen LJ, Hung MH, Shiau CW, Huang JW, Tsai MH, Chen KF. Tai WT, et al. Among authors: hung mh. Hepatology. 2016 May;63(5):1528-43. doi: 10.1002/hep.28478. Epub 2016 Mar 2. Hepatology. 2016. PMID: 26840794

9

SH2 domain-containing phosphatase 1 regulates pyruvate kinase M2 in hepatocellular carcinoma.

Tai WT, Hung MH, Chu PY, Chen YL, Chen LJ, Tsai MH, Chen MH, Shiau CW, Boo YP, Chen KF. Tai WT, et al. Among authors: hung mh. Oncotarget. 2016 Apr 19;7(16):22193-205. doi: 10.18632/oncotarget.7923. Oncotarget. 2016. PMID: 26959741 Free PMC article.

10

Dovitinib Acts As a Novel Radiosensitizer in Hepatocellular Carcinoma by Targeting SHP-1/STAT3 Signaling.

Huang CY, Tai WT, Wu SY, Shih CT, Chen MH, Tsai MH, Kuo CW, Shiau CW, Hung MH, Chen KF. Huang CY, et al. Among authors: hung mh. Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):761-71. doi: 10.1016/j.ijrobp.2016.01.016. Epub 2016 Jan 20. Int J Radiat Oncol Biol Phys. 2016. PMID: 26960749

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page